Abstract:Kathryn M Luly, 1, 2 Huilin Yang, 2, 3 Stephen J Lee, 2, 3 Wentao Wang, 1, 2 Seth D Ludwig, 2, 3 Haley E Tarbox, 4 David R Wilson, 1, 2, 5 Jordan J Green, 1– 3, 5– 10 Jamie B Spangler 1– 3, 6, 8 1 Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA; 2 Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA; 3 Department of Chemical & Biomolecular Engineering, Johns Hopkins University, Baltimore, MD, USA; 4 Department of Chemistry, Johns Hopkins University, Baltimore, MD, USA; 5 Institute for Nanobiotechnology, Johns Hopkins University, Baltimore, MD, USA; 6 Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA; 7 Bloomberg~Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA; 8 Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA; 9 Departments of Neurosurgery and Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, USA; 10 Department of Materials Science & Engineering, Johns Hopkins University, Baltimore, MD, USA Correspondence: Jamie B Spangler, Departments of Biomedical Engineering and Chemical & Biomolecular Engineering, Johns Hopkins University, 400 N Broadway, Smith 5011, Baltimore, MD, 21231, USA, Tel +1 443 287-1708, Email Jordan J Green, Department of Biomedical Engineering, Johns Hopkins University School of Medicine, 400 N Broadway, Smith 5017, Baltimore, MD, 21231, USA, Tel +1 410 614-9113, Email Purpose: Transient transfection is an essential tool for recombinant protein production, as it allows rapid screening for expression without stable integration of genetic material into a target cell genome. Poly(ethylenimine) (PEI) is the current gold standard for transient gene transfer, but transfection efficiency and the resulting protein yield are limited by the polymer's toxicity. This study investigated the use of a class of cationic polymers, poly(beta-amino ester)s (PBAEs), as reagents for transient transfection in comparison to linear 25 kDa PEI, a commonly used transfection reagent. Methods: Transfection efficiency and protein production were assessed in human embryonic kidney 293F (HEK) and Chinese hamster ovary-S (CHO) cell suspensions using PBAE-based nanoparticles in comparison to linear 25 kDa PEI. Production of both a cytosolic reporter and secreted antibodies was investigated. Results: In both HEK and CHO cells, several PBAEs demonstrated superior transfection efficiency and enhanced production of a cytosolic reporter compared to linear 25 kDa PEI. This result extended to secreted proteins, as a model PBAE increased the production of 3 different secreted antibodies compared to linear 25 kDa PEI at culture scales ranging from 20 to 2000 mL. In particular, non-viral gene transfer using the lead PBAE/plasmid DNA nanoparticle formulation led to robust transfection of mammalian cells across different constructs, doses, volumes, and cell types. Conclusion: These results show that PBAEs enhance transfection efficiency and increase protein yield compared to a widespread commercially available reagent, making them attractive candidates as reagents for use in recombinant protein production. Keywords: non-viral gene transfer, transient transfection, mammalian cell expression systems, DNA delivery Current research into chemical-based transfection methods focuses largely on optimizing agents for use in the development and production of recombinant proteins. Transient transfection, in which introduced genetic material is not incorporated into the host genome, is especially useful during the high-throughput design and screening of proteins (eg, candidate biologics) wherein stable expression is not needed. While culture conditions and plasmid design have been popular targets for optimization in transient transfection workflows, 1,2 many proteins remain difficult to express via transient transfection, and thus development of improved transfection reagents is needed to boost protein yields for applications in biomedical research and pharmaceutical design. In particular, discovery and development of next-generation antibody fusion proteins and multispecific antibodies are often limited by protein production challenges. 3,4 Chemical-based transient transfection relies on condensation and either encapsulation or complexation of plasmid DNA by a b -Abstract Truncated-

Optimizing the transient transfection process of HEK-293 suspension cells for protein production by nucleotide ratio monitoring

A high cell density transient transfection system for therapeutic protein expression based on a CHO GS-knockout cell line: process development and product quality assessment

Condition Optimization of PDGFR-β/Fc Transient Expression in HEK293F Cells

Selection and optimization of transfection enhancer additives for increased virus-like particle production in HEK293 suspension cell cultures

Tuning plasmid DNA amounts for cost-effective transfections of mammalian cells: when less is more

Nanoscale characterization coupled to multi-parametric optimization of Hi5 cell transient gene expression

Optimization of Condition for Transient Transfection of CHO-DG44 Cells

Repeated Transient Transfection: An Alternative for the Recombinant Production of Difficult-to-Express Proteins Like BMP2

Advancements in mammalian cell transient gene expression (TGE) technology for accelerated production of biologics

High cell density transient transfection of CHO cells for TGF‐β1 expression

Determination of optimum gene transfection conditions using the Taguchi method for an electroporation microchip

Production Process Reproducibility and Product Quality Consistency of Transient Gene Expression in HEK293 Cells with Anti-Pd1 Antibody As the Model Protein

Advanced Establishment of Stable Recombinant Human Suspension Cell Lines Using Genotype-Phenotype Coupling Transposon Vectors

Optimizing conditions for calcium phosphate mediated transient transfection

Effects of the dilution rate on cell cycle distribution and PEI-mediated transient gene expression by CHO cells in continuous culture

Exploring Parametric and Mechanistic Differences between Expi293FTM and ExpiCHO-STM Cells for Transient Antibody Production Optimization

Optimization of a transient antibody expression platform towards high titer and efficiency

Intracellular ribonucleotide pools as a tool for monitoring the physiological state of in vitro cultivated mammalian cells during production processes

Optimization of lentiviral vector production using polyethylenimine-mediated transfection.

Optimization of Human Antibody Gene Transient Expression in HEK293T Cell

Poly(Beta-Amino Ester)s as High-Yield Transfection Reagents for Recombinant Protein Production